Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
Clinical trial NCT02422940 · TERMINATED
Trial details
- NCT number
- NCT02422940
- Sponsor
- Acorda Therapeutics
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2017-01-01
- Enrollment
- 294
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.